Evidence map›Paper›PMID 40399474›Full record

ArticleScientific reports2025

Association between prediagnostic risk factors and survival after colorectal cancer diagnosis in Golesten cohort study.

Amirhossein Yadegar, Sahar Dalvand, Maryam Sharafkhah, Sadaf G Sepanlou, Hossein Poustchi, Gholamreza Roshandel, Mahdi Sheikh, Alireza Sadjadi, Fatemeh Mohammadi, Sahar Masoudi and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amirhossein YadegarDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sahar DalvandDepartment of Epidemiology and Biostatistics, School of Health, Tehran University of Medical Sciences, Tehran, Iran.
Maryam SharafkhahDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sadaf G SepanlouDigestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Hossein PoustchiDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Gholamreza RoshandelGolestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Mahdi SheikhGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Alireza SadjadiDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh MohammadiDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sahar MasoudiDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Reza MalekzadehDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Negar RezaeiDigestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. n.rezaei81@yahoo.com.
Alireza DelavariDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. delavari@tums.ac.ir.

Funding

World Health Organization 001
6 · The paper itself

Abstract

This study investigated the survival rates of colorectal cancer (CRC) and the association between several pre-diagnostic factors, including demographic, anthropometric, behavioral, nutritional, lifestyle, and medical history and CRC incidence and survival. Among 50,045 participants in the Golestan cohort study, 190 patients diagnosed with CRC during the follow-up period were included in this study. Cox regression and Kaplan-Meier were used for analysis. The CRC incidence risk was significantly higher in males (HR = 2.20; 1.54-3.14), adults aged 50-70 years (HR = 1.86, 1.36-2.55), adults aged 70 years and older (HR = 3.71; 2.13-6.44), and urban dwellers (HR = 1.74; 1.22-2.47). The 1-year, 2-year, and 5-year overall survival was 60.3%, 47.5%, and 35.2%, respectively. Higher pre-diagnostic socio-economic status (SES) was associated with a significantly decreased mortality (HR = 0.55; 0.34-0.89). While, age 70 years and older (HR = 2.79; 1.12-6.99), pre-diagnostic opium use (HR = 2.35; 1.36-4.07), and metastasis (HR = 2.97; 1.97-4.48) were associated with a significantly increased mortality. Health policies should be implemented to enhance healthcare services and screening programs in low-SES areas. The general population, especially males and adults aged 50 years and older should be informed about CRC screening, CRC symptoms, and healthy lifestyles and diets. Furthermore, there is a critical need to raise awareness about the harmful effects of opium on CRC.

Indexed as

Colorectal NeoplasmsAgedCohort StudiesFemaleHumansIncidenceIranKaplan-Meier EstimateLife StyleMaleMiddle AgedProportional Hazards ModelsRisk FactorsSurvival RateColorectal cancerIncidenceOpiumPre-diagnostic factorsSocioeconomic statusSurvival

Identifiers

PMID40399474
PMCPMC12095561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.